News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
894,085 Results
Type
Article (89479)
Company Profile (566)
Press Release (804018)
Multimedia
Podcasts (274)
Webinars (43)
Section
Business (267392)
Career Advice (4174)
Deals (40128)
Drug Delivery (229)
Drug Development (92044)
Employer Resources (211)
FDA (18704)
Job Trends (17543)
News (399435)
Policy (40037)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (6)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (3)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (11)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (8)
2027 Genetown Elite (6)
2027 Genetown Standard (12)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (11)
40 Under 40 (1)
Academia (3100)
Academic (2)
Accelerated approval (72)
ADA (51)
Adcomms (44)
Allergies (227)
Alliances (56998)
ALS (276)
Alzheimer's disease (2105)
Antibody-drug conjugate (ADC) (708)
Approvals (19242)
Artificial intelligence (1092)
ASCO (346)
Autoimmune disease (483)
Automation (81)
Bankruptcy (412)
Belgium (21)
Best Places to Work (12635)
BIO (81)
Biologics (59)
BIOSECURE Act (23)
Biosimilars (299)
BioSpace Insights (261)
Biotechnology (339)
Bispecific (19)
Bladder cancer (234)
Brain cancer (100)
Breast cancer (933)
Cancer (7583)
Cardiovascular disease (656)
Career advice (3632)
Career pathing (63)
CAR-T (438)
CDC (80)
CDMO (213)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1213)
Cervical cancer (63)
Clinical research (80621)
Collaboration (2778)
Commercialization (42)
Company closure (10)
Compensation (1855)
Complete response letters (126)
COVID-19 (3069)
CRISPR (141)
CRO (1)
C-suite (1648)
Cystic fibrosis (181)
Data (10275)
Decentralized trials (4)
Denatured (108)
Depression (223)
Dermatology (182)
Diabetes (824)
Diagnostics (7870)
Digital health (82)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (543)
Drug pricing (252)
Drug shortages (40)
Duchenne muscular dystrophy (377)
Earnings (103843)
Editorial (85)
Employer branding (27)
Employer resources (183)
Events (140729)
Executive appointments (1359)
Eye disease (11)
FDA (23618)
Fibrodysplasia Ossificans Progressiva (15)
Fragile X (3)
Friedreich's ataxia (26)
Frontotemporal dementia (42)
Funding (2293)
Gene editing (304)
Generative AI (112)
Gene therapy (957)
GLP-1 (1374)
Government (5617)
Grass and pollen (8)
Guidances (438)
Healthcare (21416)
Hematology (199)
HIV (118)
Huntington's disease (81)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (141)
Immunology and inflammation (416)
Immuno-oncology (147)
Indications (272)
Infectious disease (3511)
Inflammatory bowel disease (266)
Inflation Reduction Act (17)
Influenza (163)
Intellectual property (374)
Interviews (829)
IPO (18058)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (29)
Kidney disease (128)
Labor market (143)
Layoffs (719)
Leadership (67)
Legal (10179)
Licensing (76)
Liver cancer (118)
Longevity (52)
Lung cancer (1039)
Lung diease (19)
Lymphoma (538)
Machine learning (77)
Management (72)
Manufacturing (1586)
Marketing (22)
MASH (246)
Medical affairs (4)
Medical device (15454)
Medtech (15750)
Mergers & acquisitions (23565)
Metabolic disorders (2081)
mRNA (324)
Multiple sclerosis (239)
Multispecific (4)
NASH (24)
Netherlands (21)
Neurodegenerative disease (608)
Neuropsychiatric disorders (150)
Neuroscience (4198)
Neurotech (3)
NextGen: Class of 2026 (7718)
Non-profit (5171)
Now hiring (98)
Obesity (982)
Opinion (401)
Ovarian cancer (282)
Pain (334)
Pancreatic cancer (432)
Parkinson's disease (482)
Partnered (52)
Patents (791)
Patient advocacy (4)
Patient recruitment (976)
Patient selection (66)
Peanut (77)
People (68948)
Peptides (22)
Pharmaceutical (82)
Pharmacy benefit managers (42)
Phase 1 (24865)
Phase 2 (35001)
Phase 3 (26383)
Pipeline (13204)
Policy (421)
Postmarket research (3561)
Preclinical (11115)
Press Release (74)
Prostate cancer (393)
Psychedelics (96)
Radioligand (2)
Radiopharmaceuticals (434)
Rare diseases (1548)
Real estate (7477)
Recruiting (83)
Regenerative medicine (19)
Regulatory (31616)
Reports (95)
Research institute (2809)
Resumes & cover letters (656)
Rett syndrome (55)
RNA editing (36)
RSV (103)
Schizophrenia (221)
Series A (397)
Series B (278)
Service/supplier (16)
Sickle cell disease (141)
Special edition (36)
Spinal muscular atrophy (200)
Sponsored (60)
Startups (4396)
State (2)
Stem cells (3)
Stomach cancer (22)
Substance use disorders (21)
Supply chain (167)
Switzerland (1)
Tariffs (106)
The Weekly (163)
Vaccines (1410)
Venture capital (168)
Weight loss (658)
Wet AMD (5)
Women's health (179)
Women in leadership (1)
Worklife (27)
Date
Today (192)
Last 7 days (661)
Last 30 days (2849)
Last 365 days (33962)
2026 (26711)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1308)
Alabama (116)
Alaska (7)
Arizona (472)
Arkansas (17)
Asia (52961)
Australia (9321)
California (16475)
Canada (4596)
China (1924)
Colorado (715)
Connecticut (736)
Delaware (511)
Europe (122275)
Florida (2513)
Georgia (536)
Hawaii (5)
Idaho (70)
Illinois (1440)
India (145)
Indiana (751)
Iowa (32)
Japan (740)
Kansas (155)
Kentucky (68)
Louisiana (69)
Maine (97)
Maryland (1960)
Massachusetts (11932)
Michigan (466)
Minnesota (905)
Mississippi (7)
Missouri (182)
Montana (37)
Nebraska (31)
Nevada (185)
New Hampshire (93)
New Jersey (4353)
New Mexico (38)
New York (4317)
North Carolina (2151)
North Dakota (13)
Northern California (8361)
Ohio (526)
Oklahoma (31)
Oregon (51)
Pennsylvania (3156)
Puerto Rico (37)
Rhode Island (59)
South America (1673)
South Carolina (100)
South Dakota (2)
Southern California (6540)
Tennessee (277)
Texas (2741)
United States (58574)
Utah (502)
Vermont (2)
Virginia (419)
Washington D.C. (89)
Washington State (1331)
West Virginia (4)
Wisconsin (192)
Wyoming (5)
894,085 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
August 31, 2026
·
4 min read
Press Releases
Veloxis Pharmaceuticals Showcases Research at the 2026 American Transplant Congress
June 17, 2026
·
10 min read
Press Releases
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients
September 9, 2026
·
4 min read
Business
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
New data for Genmab and AbbVie’s bispecific antibody Epkinly wowed analysts and could set the partners up for an expanded approval in diffuse large B cell lymphoma; deals have flowed steadily this week, including Novartis’ nearly $8 billion bet on mRNA drugs with China’s Abogen Biosciences; and could Sarepta Therapeutics turn things around from last year’s annus horribilis?
October 7, 2026
·
2 min read
·
Jef Akst
Press Releases
Renova Pharmaceuticals Announces First Three U.S. Generic Product Launches, Marking a Major Company Milestone
September 10, 2026
·
2 min read
Press Releases
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
September 29, 2026
·
6 min read
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Cystic fibrosis
Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
A surprise flop in Phase 2a cystic fibrosis trial sent Sionna’s shares plummeting, but for Vertex, the news reinforced its standard-of-care standing with highly successful drugs like Trikafta.
August 10, 2026
·
2 min read
·
Michael Gibney
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health
June 22, 2026
·
4 min read
1 of 89,409
Next
